Follow The Filings

BLNE Beeline

Beeline earnings company data as of 4:47 AM ET 10/8

  • 0 of 1 EPS beats

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —
FY2026 Q2 14 Aug EPS -0.05 -0.32 Miss
Rev — $2.6M —

Insider trades

Open-market buys and sales by BLNE's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BLNE insider trades
  • $644K bought by 4 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Nicholas Reyland Liuzza Jr. CEO
    Buy
    $152K 148,890 shares at $1.02 +3% to stake
    Traded Sep 9–11 Filed Sep 14
  2. Nicholas Reyland Liuzza Jr. CEO
    Buy
    $99K 96,000 shares at $1.03 +2% to stake
    Traded Sep 1 Filed Sep 1
  3. Nicholas Reyland Liuzza Jr. CEO
    Buy
    $262K 267,500 shares at $0.9800 +5.9% to stake
    Traded Aug 25–31 Filed Aug 31
  4. Christopher R. Moe CFO
    Buy
    $10K 10,000 shares at $1.04 +25% to stake
    Traded May 19 Filed May 19
  5. Tiffany Milton Chief Accounting Officer
    Buy
    $15K 15,000 shares at $1.02 New stake
    Traded May 19 Filed May 19
  6. Nicholas Reyland Liuzza Jr. CEO
    Buy
    $54K 51,525 shares at $1.04 +1.2% to stake
    Traded May 19 Filed May 19
  7. Joseph David Freedman Director
    Buy
    $1,850 1,000 shares at $1.85 +0.3% to stake
    Traded Nov 26, 2025 Filed Nov 28, 2025
  8. Joseph David Freedman Director
    Buy
    $4,380 3,000 shares at $1.46 +0.8% to stake
    Traded Nov 21, 2025 Filed Nov 24, 2025
  9. Christopher R. Moe CFO
    Buy
    $34K 20,000 shares at $1.68 +100% to stake
    Traded Nov 19, 2025 Filed Nov 19, 2025
  10. Joseph David Freedman Director
    Buy
    $11K 7,000 shares at $1.62 +2% to stake
    Traded Nov 19, 2025 Filed Nov 19, 2025

Also filed in the last 12 months, not counted as buying or selling: 12 stock grants, 1 conversion, and 1 sale back to the company.

SEC filings

Recent issuer filings from EDGAR, 22 shown.

Filed Form Detail Links
8-K 7.01,9.01
8-K 7.01,9.01
8-K 7.01,9.01
8-K 7.01,9.01
8-K 7.01,9.01
8-K 7.01,9.01
8-K 5.07
10-Q
8-K 2.02,9.01
8-K 7.01,9.01
8-K 1.01,2.03,9.01
8-K 1.01,7.01,9.01
8-K 7.01,9.01
8-K 1.01,3.02,9.01
8-K 7.01,9.01
DEFA14A
DEF 14A
DEFA14A
SCHEDULE 13D/A —
SCHEDULE 13G —
8-K 7.01,9.01
8-K 5.02,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.